Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 11/14/2025 | 1.79 M | $7.80 M | 57.42% | 9.91% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2025 | 1.00 M | $4.36 M | 0.00% | 5.54% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 939.20 K | $4.09 M | 0.00% | 5.20% |
| GREAT POINT PARTNERS LLC | 11/14/2025 | 796.56 K | $3.47 M | 0.00% | 4.41% |
| VANGUARD GROUP INC | 11/07/2025 | 658.88 K | $2.87 M | 8.73% | 3.65% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 473.56 K | $2.06 M | 0.00% | 2.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 125.73 K | $548.17 K | 113.87% | 0.70% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 117.33 K | $511.55 K | 100.00% | 0.65% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2025 | 59.99 K | $261.54 K | -4.63% | 0.33% |
| STATE STREET CORP | 11/14/2025 | 54.83 K | $239.05 K | 337.81% | 0.30% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 45.20 K | $197.07 K | 100.00% | 0.25% |
| CITADEL ADVISORS LLC | 11/14/2025 | 41.67 K | $181.70 K | 100.00% | 0.23% |
| XTX TOPCO LTD | 11/14/2025 | 37.82 K | $164.91 K | 100.00% | 0.21% |
| BLACKROCK, INC. | 11/12/2025 | 36.36 K | $158.51 K | 100.00% | 0.20% |
| NORTHERN TRUST CORP | 11/14/2025 | 32.70 K | $142.57 K | 203.13% | 0.18% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 10/30/2025 | 26.96 K | $127.26 K | 100.00% | 0.15% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 23.95 K | $104.41 K | 100.00% | 0.13% |
| MORGAN STANLEY | 11/14/2025 | 10.61 K | $46.27 K | 961.20% | 0.06% |
| CITIGROUP INC | 11/10/2025 | 6.69 K | $29.18 K | 100.00% | 0.04% |
| UBS GROUP AG | 11/13/2025 | 5.45 K | $23.74 K | 100.00% | 0.03% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 827 | $3.61 K | 1,192.19% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 560 | $2.44 K | 1.27% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2025 | 500 | $2.18 K | 100.00% | 0.00% |
| TFC FINANCIAL MANAGEMENT, INC. | 10/24/2025 | 300 | $1.31 K | 100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 10/17/2025 | 107 | $467 | 100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/12/2025 | 100 | $436 | 0.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 80 | $349 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 55 | $240 | 100.00% | 0.00% |
| BOGART WEALTH, LLC | 10/27/2025 | 6 | $26 | 0.00% | 0.00% |
| DANSKE BANK A/S | 11/19/2025 | 1 | $4 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| LAZARD ASSET MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Unicycive Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 35 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 1.79 M
Octagon Capital Advisors LP: 1,000,000
Nantahala Capital Management, LLC: 939,202
GREAT POINT PARTNERS LLC: 796,558
VANGUARD GROUP INC: 658,878
Logos Global Management LP: 473,563
34.80% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.36 M shares in the last 24 months. This purchase volume represents approximately $29.37 M in transactions.